eConsent in Healthcare Market Size & Share 2024 – 2032

eConsent In Healthcare Market Size

eConsent in Healthcare Market was valued at USD 458.2 million in 2023 and is anticipated to witness growth at a CAGR of 10.6% between 2024 and 2032. The eConsent in the healthcare market is experiencing growth driven by the expansion and globalization of clinical trials, increasing awareness among patients, and the rise of telehealth and remote care services.

The globalization of clinical trials involves conducting studies across multiple countries and regions, each with its own regulatory requirements and cultural nuances. eConsent platforms provide a standardized yet flexible approach to obtaining informed consent, ensuring compliance with diverse regulatory frameworks. Digital consent forms can be easily adapted and translated to meet the specific needs of different jurisdictions, streamlining multinational clinical trial operations.
 

Additionally, eConsent solutions integrated with telehealth platforms enhance patient engagement by providing clear and easily understandable information about medical procedures, treatments, and clinical trials. Patients can access consent documents, educational materials, and multimedia resources online, ensuring they are well-informed before making decisions. This transparency and accessibility increase patient confidence and participation in their healthcare.
 

eConsent in healthcare refers to the electronic process of obtaining and managing informed consent from patients or clinical trial participants through digital platforms.
 

eConsent In Healthcare Market Trends

The shift towards digital health records and electronic processes is part of a broader movement towards digital transformation in the healthcare industry, aiming to improve efficiency, accuracy, and patient experience.
 

• As healthcare systems increasingly adopt electronic health records (EHRs), integrating eConsent solutions becomes a natural progression. eConsent platforms can seamlessly integrate with EHR systems, ensuring that consent forms and related documents are stored, managed, and accessed digitally. This integration enhances the efficiency of healthcare operations by providing healthcare professionals with quick access to consent information directly within patient records, reducing administrative burdens and improving care coordination.
   
• Additionally, the digital nature of eConsent platforms ensures higher accuracy and consistency in capturing patient consent compared to traditional paper-based methods. Electronic processes reduce the risk of errors, omissions, and inconsistencies, which are common in manual documentation. Accurate and consistent consent records are crucial for regulatory compliance, clinical decision-making, and maintaining the integrity of patient data.
   
• Furthermore, eConsent solutions provide a more streamlined and user-friendly experience for patients. They can review, understand, and sign consent forms electronically, at their convenience, using devices such as smartphones, tablets, or computers. The digital format can also include multimedia elements like videos, infographics, and interactive content to help patients better understand the information, leading to more informed decision-making and higher satisfaction, contributing to the market growth.
   

eConsent In Healthcare Market Analysis

Based on deployment mode, the market is segmented into cloud-based and on-premises. The cloud-based segment held a dominant market share of 76.7% in 2023.
 

• Unlike traditional methods, cloud-based eConsent solutions provide anytime, anywhere access to consent forms and information. This accessibility enhances patient engagement and streamlines administrative workflows for healthcare providers.
   
• Additionally, cloud platforms offer scalability, allowing healthcare organizations to adjust resources based on demand. This flexibility reduces infrastructure costs associated with maintaining on-premises systems, making it financially viable for organizations of all sizes, and contributing to their dominant market share.
   

Based on application, the eConsent in healthcare market is categorized into clinical trials, treatment consent, and telemedicine. The clinical trials segment is projected to reach USD 793 million by 2032.
 

• Clinical trials, pivotal in advancing medical research and treatment development, rely heavily on efficient and compliant consent processes. eConsent solutions offer significant advantages here, streamlining the consent process by providing multimedia tools for patient education, ensuring comprehension through quizzes and assessments, and enabling remote participation options. These features not only enhance patient engagement but also improve compliance with regulatory standards, thereby accelerating the initiation and progress of clinical trials.
   
• Additionally, eConsent applications in clinical trials contribute to enhancing patient autonomy and understanding. By presenting information in a clear, accessible manner and allowing patients to review materials at their own pace, these solutions empower individuals to make informed decisions about their participation in trials. This not only improves the quality of consent but also fosters trust between patients, healthcare providers, and research institutions, crucial for the success and ethical conduct of trials.
   

Based on workflow integration, the eConsent in healthcare market is categorized into integrated solutions and standalone solutions. The integrated solutions market size in 2023 was valued at USD 374.9 million.
 

• By seamlessly integrating with electronic health records (EHR) and clinical trial management systems (CTMS), these eClinical solutions facilitate a streamlined consent process. This integration allows for real-time access to patient data, enabling researchers and clinicians to personalize consent materials based on individual patient profiles and medical histories.
   
• Additionally, in chronic disease management, integrated eConsent solutions support ongoing patient engagement by integrating with patient portals and remote monitoring systems. This integration enables healthcare providers to update consent forms in real-time as treatment plans evolve, ensuring that patients remain informed about their care options and actively participate in decision-making processes. Such integration enhances continuity of care, improves treatment adherence, and fosters a collaborative relationship between patients and healthcare teams.
   

Based on user interface, the eConsent in healthcare market is categorized into web-based platforms and mobile applications. The web-based platforms segment market is anticipated to grow at a CAGR of 10.4% to reach USD 722.6 million by 2032.
 

• Web-based eConsent platforms have revolutionized the consent process by providing intuitive interfaces that are accessible to both researchers and participants. These platforms enable researchers to create interactive consent forms enriched with multimedia content such as videos, animations, and interactive quizzes. Such features enhance patient comprehension of study protocols and risks, thereby improving the quality of informed consent.
   
• Additionally, beyond clinical trials, web-based eConsent platforms are also making significant inroads in hospital settings, outpatient clinics, and telehealth environments. These platforms integrate seamlessly with electronic health record (EHR) systems and patient management software, ensuring that consent documentation is captured electronically and stored securely. This integration enhances workflow efficiency by reducing administrative burdens associated with paper-based consent forms and enabling real-time access to consent status for healthcare providers.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end-use, the eConsent in healthcare market is categorized into clinical research organizations, hospitals and clinics, pharmaceutical and biotech companies, and other end-users. The clinical research organizations segment dominated the market size in 2023 and was valued at USD 270.4 million.
 

• eConsent solutions empower clinical research organizations (CROs) to enhance participant engagement and understanding of study protocols. These solutions enable CROs to present complex study information in a clear, multimedia-rich format, including videos, interactive modules, and FAQs. Such features help participants make informed decisions about their participation in clinical trials, thereby fostering trust and compliance with ethical standards.
   
• Additionally, eConsent platforms support multilingual capabilities and accessibility features, accommodating diverse participant demographics and ensuring inclusivity in consent processes.
   

North America eConsent in healthcare market size in 2023 was valued at USD 200.6 million and is predicted to grow at a CAGR of 10.1% over the analysis timeframe.
 

• North America holds a significant market share in the eConsent sector within the healthcare market, driven by technological advancements, stringent regulatory frameworks, and a strong emphasis on patient-centric care.
   
• Additionally, the adoption of eConsent solutions is propelled by the need to streamline consent processes in clinical trials, healthcare facilities, and telehealth services. Regulatory compliance, particularly with HIPAA regulations, incentivizes healthcare providers and research organizations to implement secure, electronic consent platforms.
   

The U.S. eConsent in healthcare market is anticipated to grow at a CAGR of 9.9% to reach USD 437.2 million by 2032.
 

• Within the U.S., eConsent solutions have gained traction across various healthcare settings, including hospitals, research institutions, pharmaceutical companies, and telehealth providers.
   
• In clinical research, U.S. based organizations leverage eConsent platforms to streamline the consent process for clinical trials, ensuring compliance with FDA regulations and enhancing participant engagement.
   
• These platforms enable researchers to deliver consent materials electronically, track participant interactions in real time, and integrate consent data with electronic data capture (EDC) systems. Such capabilities improve study efficiency, data accuracy, and transparency in research practices.
   

Germany eConsent in healthcare market is projected to grow remarkably in the coming years.
 

• The adoption of eConsent solutions in Germany is fueled by efforts to improve patient autonomy, streamline consent processes, and enhance compliance with EU data privacy laws, including GDPR (General Data Protection Regulation).
   
• Additionally, the country’s eConsent market benefits from a competitive landscape of technology vendors offering scalable, interoperable platforms designed to meet the diverse needs of healthcare providers, research institutions, and pharmaceutical companies. Investments in cybersecurity infrastructure and data encryption technologies ensure the secure handling of sensitive patient information, fostering trust and compliance with regulatory requirements.
   

Japan is experiencing high market growth in the eConsent healthcare market.
 

• The adoption of eConsent solutions in Japan is driven by efforts to improve healthcare efficiency, ensure regulatory compliance, and empower patients in their treatment decisions.
   
• Additionally, the country’s commitment to clinical research and collaboration with international clinical research organizations further strengthens its market presence.
   

eConsent In Healthcare Market Share

The eConsent in healthcare industry is characterized by the presence of several established and emerging players that offer a variety of services across the globe. The market players compete based on factors such as service quality, innovation, regulatory compliance, customer service, and pricing strategies.
 

eConsent In Healthcare Market Companies

Prominent players operating in the eConsent in healthcare industry include:

• Advarra
• Calysta EM
• Castor
• Climedo Health GmbH
• Clinical ink
• Concentric Health Ltd
• Epic Communications
• EvidentIQ Group GmbH
• Florence Healthcare
• Interlace Health
• IQVIA
• Obvio Health USA, Inc.
• Signant Health
• Suvoda LLC
• Veeva Systems
   

eConsent In Healthcare Industry News:

• In January 2024, Advarra announced a new site-specific eConsent module in the Advarra clinical trial technology portfolio. Advarra’s new eConsent module makes it easier for sites to compliantly manage a complicated and ongoing consenting process. This service launch may help the company to enhance its eConsent portfolio and offerings to customers.
   

The eConsent in healthcare market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Deployment Mode

• Cloud-based
• On-premises

Market, By Application

• Clinical trials
• Treatment consent
• Telemedicine

Market, By Workflow Integration

• Integrated solutions
• Standalone solutions

Market, By User Interface

• Web-based platforms
• Mobile applications

Market, By End-use

• Clinical research organizations
• Hospitals and clinics
• Pharmaceutical and biotech companies
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa